These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10325788)

  • 101. Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step.
    Pollitt RJ; Dalton A; Evans S; Hughes HN; Curtis D
    J Med Screen; 1997; 4(1):23-8. PubMed ID: 9200059
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Newborn screening for cystic fibrosis: do we need a second IRT?
    Price JF
    Arch Dis Child; 2006 Mar; 91(3):209-10. PubMed ID: 16492882
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The Impact of the CFTR Gene Discovery on Cystic Fibrosis Diagnosis, Counseling, and Preventive Therapy.
    Farrell PM; Rock MJ; Baker MW
    Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32276344
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Neonatal screening of cystic fibrosis: diagnostic problems with CFTR mild mutations.
    Roussey M; Le Bihannic A; Scotet V; Audrezet MP; Blayau M; Dagorne M; David V; Deneuville E; Giniès JL; Laurans M; Moisan-Petit V; Rault G; Vigneron P; Férec C
    J Inherit Metab Dis; 2007 Aug; 30(4):613. PubMed ID: 17632692
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Assessing the improvements in the newborn screening strategy for cystic fibrosis in the Balearic Islands.
    Bauça JM; Morell-Garcia D; Vila M; Pérez G; Heine-Suñer D; Figuerola J
    Clin Biochem; 2015 Apr; 48(6):419-24. PubMed ID: 25680858
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Diagnosis of Cystic Fibrosis in Screened Populations.
    Farrell PM; White TB; Howenstine MS; Munck A; Parad RB; Rosenfeld M; Sommerburg O; Accurso FJ; Davies JC; Rock MJ; Sanders DB; Wilschanski M; Sermet-Gaudelus I; Blau H; Gartner S; McColley SA
    J Pediatr; 2017 Feb; 181S():S33-S44.e2. PubMed ID: 28129810
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Cystic Fibrosis Diagnosis and Newborn Screening.
    Rosenfeld M; Sontag MK; Ren CL
    Pediatr Clin North Am; 2016 Aug; 63(4):599-615. PubMed ID: 27469178
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
    Hammond KB; Abman SH; Sokol RJ; Accurso FJ
    N Engl J Med; 1991 Sep; 325(11):769-74. PubMed ID: 1870650
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Extended gene analysis can increase specificity of neonatal screening for cystic fibrosis.
    Mérelle ME; Scheffer H; De Jong D; Dankert-Roelse JE
    Acta Paediatr; 2006 Nov; 95(11):1424-8. PubMed ID: 17062471
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Newborn screening and carrier screening for cystic fibrosis: alternative or complementary?
    Castellani C; Massie J
    Eur Respir J; 2014 Jan; 43(1):20-3. PubMed ID: 24381320
    [No Abstract]   [Full Text] [Related]  

  • 111. European survey of newborn bloodspot screening for CF: opportunity to address challenges and improve performance.
    Munck A; Berger DO; Southern KW; Carducci C; de Winter-de Groot KM; Gartner S; Kashirskaya N; Linnane B; Proesmans M; Sands D; Sommerburg O; Castellani C; Barben J;
    J Cyst Fibros; 2023 May; 22(3):484-495. PubMed ID: 36372700
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Pancreatic function and extended mutation analysis in DeltaF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levels.
    Massie RJ; Wilcken B; Van Asperen P; Dorney S; Gruca M; Wiley V; Gaskin K
    J Pediatr; 2000 Aug; 137(2):214-20. PubMed ID: 10931414
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Immunoreactive trypsin levels in neonates with meconium ileus.
    Steven LC; Gavel G; Young D; Carachi R
    Pediatr Surg Int; 2006 Mar; 22(3):236-9. PubMed ID: 16395608
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Variation in immunoreactive trypsinogen concentrations among Michigan newborns and implications for cystic fibrosis newborn screening.
    Korzeniewski SJ; Young WI; Hawkins HC; Cavanagh K; Nasr SZ; Langbo C; Teneyck KR; Grosse SD; Kleyn M; Grigorescu V
    Pediatr Pulmonol; 2011 Feb; 46(2):125-30. PubMed ID: 20848586
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Immunoreactive trypsinogen screening for cystic fibrosis: characterization of infants with a false-positive screening test.
    Rock MJ; Mischler EH; Farrell PM; Bruns WT; Hassemer DJ; Laessig RH
    Pediatr Pulmonol; 1989; 6(1):42-8. PubMed ID: 2704582
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
    Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
    Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [Mucoviscidosis screening of newborn infants in the Dresden district. Results from 1 June 1996 to 31 March 2000].
    Wunderlich P; Stopsack M; Paul KD; Rösen-Wolff A
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1356-60. PubMed ID: 11109423
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Improving test properties for neonatal cystic fibrosis screening in the Netherlands before the nationwide start by May 1st 2011.
    Cornel MC; Gille JJ; Loeber JG; Vernooij-van Langen AM; Dankert-Roelse J; Bolhuis PA
    J Inherit Metab Dis; 2012 Jul; 35(4):635-40. PubMed ID: 22302635
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Cystic fibrosis: newborn screening in America.
    Kleven DT; McCudden CR; Willis MS
    MLO Med Lab Obs; 2008 Jul; 40(7):16-8, 22, 24-7. PubMed ID: 18717498
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs.
    Martiniano SL; Croak K; Bonn G; Sontag MK; Sagel SD
    Mol Genet Metab; 2021; 134(1-2):65-67. PubMed ID: 34489170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.